...
首页> 外文期刊>Angewandte Chemie >Potent Inhibitors of tRNA-Guanine Transglycosylase,an Enzyme Linked to the Pathogenicity of the Shigella Bacterium:Charge-Assisted Hydrogen Bonding
【24h】

Potent Inhibitors of tRNA-Guanine Transglycosylase,an Enzyme Linked to the Pathogenicity of the Shigella Bacterium:Charge-Assisted Hydrogen Bonding

机译:tRNA-鸟嘌呤转糖基酶的强效抑制剂,一种与志贺氏菌细菌致病性相关的酶:电荷辅助氢键

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

tRNA-Guanine transglycosylase(TGT,EC 2.4.2.29)is a tRNA-modifying enzyme common to nearly all organisms including humans.In bacteria,TGT catalyzes the exchange of guanine in position 34 by preQ_1,whereas eukaryotic TGT accelerates the replacement by queuine.This difference in substrate specificity offers the possibility for selective inhibition of the bacterial enzyme,which has been linked to the pathogenicity of Shigella,the causative agent of bacillary dysentery(Shigellosis),a diarrheal disease responsible for more than a million deaths annually.As substantial crystallographic and biochemical information about the bacterial enzyme is available,TGT represents an ideal target for structure-based drug design to facilitate the development of selective antibiotics against bacillary dysentery.
机译:tRNA-鸟嘌呤转糖基酶(TGT,EC 2.4.2.29)是几乎所有生物体(包括人类)都共有的一种tRNA修饰酶。在细菌中,TGT催化preQ_1催化34位鸟嘌呤的交换,而真核生物TGT则加快了奎宁的替代。底物特异性的这种差异为细菌酶的选择性抑制提供了可能性,该细菌酶与志贺氏菌的致病性有关。志贺氏菌是一种细菌性痢疾的病原体,而痢疾是一种痢疾,每年导致一百万人死亡。可获得有关细菌酶的晶体学和生化信息,TGT代表了基于结构的药物设计的理想目标,以促进针对细菌性痢疾的选择性抗生素的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号